What's president Trump's impact on Biotech?

[muscleman]

I don't understand why the Biotech ETF gained so much in the recent days.

 

Biotech seems to be the beneficiary of Obamacare, which forces everyone to carry an insurance, so they raised drug prices by 400-10000% and consumers don't know.

 

Now if ObamaCare is voided and competition brought in, won't that be bad for these Biotech companies?  ::)

 

[rb]

If i remember correctly Obama put some curbs specifically for biotech of just how much they can raise prices. Hillary also said some not so nice things about drug prices and drug companies too.

[DooDiligence]

I don't understand why the Biotech ETF gained so much in the recent days.

 

Biotech seems to be the beneficiary of Obamacare, which forces everyone to carry an insurance, so they raised drug prices by 400-10000% and consumers don't know.

 

Now if ObamaCare is voided and competition brought in, won't that be bad for these Biotech companies?  ::)

 

Too many variables for me to guess.

 

My rationale for owning BBH, XBI & NVO are that we've been pounding roots & such for 1000's of years & we'll continue to do so.

 

BBH gives me exposure to large cap & XBI takes care of small & mid cap.

 

I believe that the world is getting fatter & I like Novo's focus (wish it'd keep dropping so I could round out my position...)

 

I don't even factor in government intervention (it's a leap of faith...)

[Spekulatius]

BNTX and MRNA trading around 1.2x tangible book (which is mostly cash). Both have products on the market and significant pipelines. Perhaps too significant for MRNA as they may have trouble financing it, but what do I know. Seems cheap though.

 

[Lazarus]

RFK's impact on Pharma and biotech is a wild card. 

[Castanza]

On 11/22/2024 at 9:00 AM, Lazarus said:

RFK's impact on Pharma and biotech is a wild card. 

 

Not something I have a good handle on (and clearly the market doesn't either); but a basket play here might not be a bad option.